Resistance to Selective FGFR Inhibitors in FGFR- Driven Urothelial Cancer

Facchinetti, F; Hollebecque, A; Braye, F; Vasseur, D; Pradat, Y; Bahleda, R; Pobel, C; Bigot, L; Deas, O; Arango, JD; Guaitoli, G; Mizuta, H; Combarel, D; Tselikas, L; Michiels, S; Nikolaev, SI; Scoazec, JY; Ponce-Aix, S; Besse, B; Olaussen, KA; Loriot, Y; Friboulet, L

Friboulet, L (通讯作者)，Gustave Roussy Canc Campus, INSERM, U981, 114 Rue Edouard Vaillant, F-94800 Villejuif, France.

CANCER DISCOVERY, 2023; 13 (9): 1998

Abstract

Several fibroblast growth factor receptor (FGFR) inhibitors are approved or in clinical development for the treatment of FGFR-driven urothelial cancer......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索